Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.

Pericàs JM, Nathavitharana R, Garcia-de-la-Mària C, Falces C, Ambrosioni J, Almela M, García-González J, Quintana E, Marco F, Moreno A, Bayer AS, Miró JM, Karchmer AW; Hospital Clínic Endocarditis Study Group.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516-19. doi: 10.1128/AAC.00516-19. [Epub ahead of print]

PMID:
31182540
2.

E157Q integrase strand-transfer inhibitor substitution in patients with acute/recent HIV infection.

Ambrosioni J, Rico JÁF, Nicolás D, Mosquera MM, de Lazzari E, Marcos MÁ, García F, Miró JM; Hospital Clinic Acute/Recent HIV infection Study Group.

AIDS. 2019 May 6. doi: 10.1097/QAD.0000000000002243. [Epub ahead of print]

PMID:
31090546
3.

Role of age and comorbidities in mortality of patients with infective endocarditis.

Armiñanzas C, Fariñas-Alvarez C, Zarauza J, Muñoz P, González Ramallo V, Martínez Sellés M, Miró Meda JM, Pericás JM, Goenaga MÁ, Ojeda Burgos G, Rodríguez Álvarez R, Castelo Corral L, Gálvez-Acebal J, Martínez Marcos FJ, Fariñas MC; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espana Study Group, Fernández Sánchez F, Noureddine M, Rosas G, de la Torre Lima J, Aramendi J, Bereciartua E, Blanco MJ, Blanco R, Boado MV, Campaña Lázaro M, Crespo A, Goikoetxea J, Iruretagoyena JR, Irurzun Zuazabal J, López-Soria L, Montejo M, Nieto J, Rodrigo D, Rodríguez D, Rodríguez R, Vitoria Y, Voces R, García López MV, Georgieva RI, Ojeda G, Rodríguez Bailón I, Ruiz Morales J, Cuende AM, Echeverría T, Fuerte A, Gaminde E, Goenaga MÁ, Idígoras P, Iribarren JA, Izaguirre Yarza A, Kortajarena Urkola X, Reviejo C, Carrasco R, Climent V, Llamas P, Merino E, Plazas J, Reus S, Álvarez N, Bravo-Ferrer JM, Castelo L, Cuenca J, Llinares P, Miguez Rey E, Rodríguez Mayo M, Sánchez E, Sousa Regueiro D, Martínez FJ, Alonso MDM, Castro B, García Rosado D, Durán MDC, Miguel Gómez MA, Lacalzada J, Nassar I, Plata Ciezar A, Reguera Iglesias JM, Asensi Álvarez V, Costas C, de la Hera J, Fernández Suárez J, Iglesias Fraile L, León Arguero V, López Menéndez J, Mencia Bajo P, Morales C, Moreno Torrico A, Palomo C, Paya Martínez B, Rodríguez Esteban Á, Rodríguez García R, Telenti Asensio M, Almela M, Ambrosioni J, Azqueta M, Brunet M, Bodro M, Cartañá R, Falces C, Fita G, Fuster D, García de la Mària C, Hernández-Meneses M, Llopis Pérez J, Marco F, Miró JM, Moreno A, Nicolás D, Ninot S, Quintana E, Paré C, Pereda D, Pericás JM, Pomar JL, Ramírez J, Rovira I, Sandoval E, Sitges M, Soy D, Téllez A, Tolosana JM, Vidal B, Vila J, Adán I, Bermejo J, Bouza E, Celemín D, Cuerpo Caballero G, Delgado Montero A, Fernández Cruz A, García Mansilla A, García Leoni ME, González Ramallo V, Kestler Hernández M, Hualde AM, Marín M, Martínez-Sellés M, Menárguez MC, Muñoz P, Rincón C, Rodríguez-Abella H, Rodríguez-Créixems M, Pinilla B, Pinto Á, Valerio M, Vázquez P, Verde Moreno E, Antorrena I, Loeches B, Martín Quirós A, Moreno M, Ramírez U, Rial Bastón V, Romero M, Saldaña A, Agüero Balbín J, Amado C, Armiñanzas Castillo C, Arnaiz García A, Cobo Belaustegui M, Fariñas MC, Fariñas-Álvarez C, Gómez Izquierdo R, García I, González-Rico C, Gutiérrez-Cuadra M, Gutiérrez Díez J, Pajarón M, Parra JA, Sarralde A, Teira R, Zarauza J, Domínguez F, García Pavía P, González J, Orden B, Ramos A, Centella T, Hermida JM, Moya JL, Martín-Dávila P, Navas E, Oliva E, Del Río A, Ruiz S, Hidalgo Tenorio C, Almendro Delia M, Araji O, Barquero JM, Calvo Jambrina R, de Cueto M, Gálvez Acebal J, Méndez I, Morales I, López-Cortés LE, de Alarcón A, García E, Haro JL, Lepe JA, López F, Luque R, Alonso LJ, Azcárate P, Azcona Gutiérrez JM, Blanco JR, García-Álvarez L, Oteo JA, Sanz M, de Benito N, Gurguí M, Pacho C, Pericas R, Pons G, Álvarez M, Fernández AL, Martínez A, Prieto A, Regueiro B, Tijeira E, Vega M, Canut Blasco A, Cordo Mollar J, Gainzarain Arana JC, García Uriarte O, Martín López A, Ortiz de Zárate Z, Urturi Matos JA, García Domínguez G, Sánchez-Porto A, Arribas Leal JM, García Vázquez E, Hernández Torres A, Blázquez A, de la Morena Valenzuela G, Alonso Á, Aramburu J, Calvo FE, Moreno Rodríguez A, Tarabini-Castellani P, Heredero Gálvez E, Maicas Bellido C, Largo Pau J, Sepúlveda MA, Toledano Sierra P, Iqbal-Mirza SZ, Cascales Alcolea E, Egea Serrano P, Hernández Roca JJ, Keituqwa Yañez I, Peláez Ballesta A, Soriano V, Moreno Escobar E, Peña Monje A, Sánchez Cabrera V, Vinuesa García D, Arrizabalaga Asenjo M, Cifuentes Luna C, Núñez Morcillo J, Pérez Seco MC, Villoslada Gelabert A, Aured Guallar C, Fernández Abad N, García Mangas P, Matamala Adell M, Palacián Ruiz MP, Porres JC, Alcaraz Vidal B, Cobos Trigueros N, Del Amor Espín MJ, Giner Caro JA, Jiménez Sánchez R, Jimeno Almazán A, Ortín Freire A, Viqueira González M, Pericás Ramis P, Ribas Blanco MÁ, Ruiz de Gopegui Bordes E, Vidal Bonet L, Bellón Munera MC, Escribano Garaizabal E, Tercero Martínez A, Segura Luque JC.

Eur J Intern Med. 2019 Jun;64:63-71. doi: 10.1016/j.ejim.2019.03.006. Epub 2019 Mar 21.

PMID:
30904433
4.

Effect of the type of surgical indication on mortality in patients with infective endocarditis who are rejected for surgical intervention.

Ramos-Martínez A, Calderón-Parra J, Miró JM, Muñoz P, Rodríguez-Abella H, Valerio M, de Alarcón A, Luque R, Ambrosioni J, Fariñas MC, Goenaga MÁ, Oteo JA, Martínez Marcos FJ, Vinuesa D, Domínguez F; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) (see Appendix).

Int J Cardiol. 2019 May 1;282:24-30. doi: 10.1016/j.ijcard.2019.01.014. Epub 2019 Jan 10.

PMID:
30718134
5.

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.

Llibre JM, Montoliu A, Miró JM, Domingo P, Riera M, Tiraboschi J, Curran A, Homar F, Ambrosioni J, Abdulghani N, Force L, Peraire J, Casabona J; PISCIS Cohort group.

HIV Med. 2019 Mar;20(3):237-247. doi: 10.1111/hiv.12710. Epub 2019 Jan 27.

PMID:
30688007
6.

Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort.

Pericàs JM, Llopis J, González-Ramallo V, Goenaga MÁ, Muñoz P, García-Leoni ME, Fariñas MC, Pajarón M, Ambrosioni J, Luque R, Goikoetxea J, Oteo JA, Carrizo E, Bodro M, Reguera-Iglesias JM, Navas E, Hidalgo-Tenorio C, Miró JM; GAMES investigators.

Clin Infect Dis. 2019 Jan 14. doi: 10.1093/cid/ciz030. [Epub ahead of print]

PMID:
30649282
7.

New option for ART in patients with HIV on dialysis.

Ambrosioni J, Miro JM.

Lancet HIV. 2018 Dec 13. pii: S2352-3018(18)30290-X. doi: 10.1016/S2352-3018(18)30290-X. [Epub ahead of print] No abstract available.

PMID:
30555050
8.

Resistance Testing for Integrase Strand Transfer Inhibitors in Naive, Human Immunodeficiency Virus-infected Individuals.

Ambrosioni J, Mosquera M, Miró JM.

Clin Infect Dis. 2019 May 17;68(11):1976-1977. doi: 10.1093/cid/ciy1019. No abstract available.

PMID:
30520993
9.

Baseline Genotype Testing to Assess Drug Resistance Before Beginning HIV Treatment.

Ambrosioni J, Mosquera M, Miró JM.

JAMA. 2018 Nov 27;320(20):2153-2154. doi: 10.1001/jama.2018.15926. No abstract available.

PMID:
30480719
10.

Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997-2015): a prospective cohort study.

Nicolás D, Ambrosioni J, de Lazzari E, Suarez A, Manzardo C, Agüero F, Mosquera MM, Costa J, Ligero C, Marcos MÁ, Sánchez-Palomino S, Fernández E, Plana M, Yerly S, Gatell JM, Miró JM; Hospital Clinic Acute/Recent HIV Study Group.

Clin Microbiol Infect. 2019 Jul;25(7):878-884. doi: 10.1016/j.cmi.2018.10.021. Epub 2018 Nov 22.

PMID:
30472421
11.

HACEK infective endocarditis: Epidemiology, clinical features, and outcome: A case-control study.

Ambrosioni J, Martinez-Garcia C, Llopis J, Garcia-de-la-Maria C, Hernández-Meneses M, Tellez A, Falces C, Almela M, Vidal B, Sandoval E, Fuster D, Quintana E, Tolosana JM, Marco F, Moreno A, Miró JM; Hospital Clinic Infective Endocarditis Investigators.

Int J Infect Dis. 2018 Nov;76:120-125. doi: 10.1016/j.ijid.2018.08.013. Epub 2018 Aug 25.

12.

Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.

Bermejo M, Ambrosioni J, Bautista G, Climent N, Mateos E, Rovira C, Rodríguez-Mora S, López-Huertas MR, García-Gutiérrez V, Steegmann JL, Duarte R, Cervantes F, Plana M, Miró JM, Alcamí J, Coiras M.

Biochem Pharmacol. 2018 Oct;156:248-264. doi: 10.1016/j.bcp.2018.08.031. Epub 2018 Aug 22.

PMID:
30142322
13.

Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Ripa M, Morata L, Rodríguez-Núñez O, Cardozo C, Puerta-Alcalde P, Hernández-Meneses M, Ambrosioni J, Linares L, Bodro M, Valcárcel A, Casals C, Guerrero-León MLA, Almela M, Garcia-Vidal C, Del Río A, Marco F, Mensa J, Martínez JA, Soriano A.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00892-18. doi: 10.1128/AAC.00892-18. Print 2018 Nov.

14.

Twenty-year experience with cryopreserved arterial allografts for vascular infections.

Mestres CA, Quintana E, Kopjar T, Ambrosioni J, Almela M, Fuster D, Ninot S, Miró JM; Hospital Clinic Infective Endocarditis Investigators.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):358-365. doi: 10.1093/ejcts/ezy263.

PMID:
30084901
15.

Diagnostic yield of 18F-FDG PET/CT in suspected diagnosis of vascular graft infection: A prospective cohort study.

Bowles H, Ambrosioni J, Mestres G, Hernández-Meneses M, Sánchez N, Llopis J, Yugueros X, Almela M, Moreno A, Riambau V, Fuster D, Miró JM; Hospital Clinic Endocarditis Study Group.

J Nucl Cardiol. 2018 Jun 15. doi: 10.1007/s12350-018-1337-1. [Epub ahead of print]

PMID:
29907934
16.

Reply to Garcia-Granja et al.

Ambrosioni J, Tellez A, Hernandez-Meneses M, Llopis J, Moreno A, Miró JM; Hospital Clinic Infective Endocarditis Investigators.

Clin Infect Dis. 2018 Nov 13;67(11):1801. doi: 10.1093/cid/ciy446. No abstract available.

PMID:
29788043
17.

Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.

Cristelli MP, Trullàs JC, Cofán F, Rico N, Manzardo C, Ambrosioni J, Bedini JL, Moreno A, Diekmann F, Miro JM; CKD-H. Clinical Investigators.

Braz J Infect Dis. 2018 May - Jun;22(3):193-201. doi: 10.1016/j.bjid.2018.05.001. Epub 2018 May 18.

18.

Reply to Cuervo et al.

Ambrosioni J, Urra X, Llopis J, Moreno A, Chamorro A, Miró JM; Hospital Clinic Infective Endocarditis Investigators.

Clin Infect Dis. 2018 Sep 14;67(7):1146-1147. doi: 10.1093/cid/ciy305. No abstract available.

PMID:
29688284
19.

The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.

García-de-la-Mària C, Gasch O, García-Gonzalez J, Soy D, Shaw E, Ambrosioni J, Almela M, Pericàs JM, Tellez A, Falces C, Hernandez-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Pujol M, Moreno A, Marco F, Miró JM.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02633-17. doi: 10.1128/AAC.02633-17. Print 2018 Jun.

20.

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

Ryom L, Boesecke C, Bracchi M, Ambrosioni J, Pozniak A, Arribas J, Behrens G, Mallon P, Puoti M, Rauch A, Miro JM, Kirk O, Marzolini C, Lundgren JD, Battegay M; EACS Governing Board.

HIV Med. 2018 May;19(5):309-315. doi: 10.1111/hiv.12600. Epub 2018 Mar 1.

21.

Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population.

Reyes-Urueña JM, Campbell CNJ, Vives N, Esteve A, Ambrosioni J, Tural C, Ferrer E, Navarro G, Force L, García I, Masabeu À, Vilaró JM, García de Olalla P, Caylà JA, Miró JM, Casabona J; PISCIS investigators.

BMJ Open. 2018 Feb 28;8(2):e018533. doi: 10.1136/bmjopen-2017-018533.

22.

Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.

Rakotoarivelo R, Ambrosioni J, Rasolofo V, Raberahona M, Rakotosamimanana N, Andrianasolo R, Ramanampamonjy R, Tiaray M, Razafimahefa J, Rakotoson J, Randria M, Bonnet F, Calmy A; MadaXpert Study Group.

Int J Infect Dis. 2018 Apr;69:20-25. doi: 10.1016/j.ijid.2018.01.017. Epub 2018 Mar 1.

23.

Mechanical Thrombectomy for Acute Ischemic Stroke Secondary to Infective Endocarditis.

Ambrosioni J, Urra X, Hernández-Meneses M, Almela M, Falces C, Tellez A, Quintana E, Fuster D, Sandoval E, Vidal B, Tolosana JM, Moreno A, Chamorro A, Miró JM; Hospital Clínic Infective Endocarditis Study Group .

Clin Infect Dis. 2018 Apr 3;66(8):1286-1289. doi: 10.1093/cid/cix1000.

PMID:
29136121
24.

Epidemiology, Clinical Features, and Outcome of Infective Endocarditis due to Abiotrophia Species and Granulicatella Species: Report of 76 Cases, 2000-2015.

Téllez A, Ambrosioni J, Llopis J, Pericàs JM, Falces C, Almela M, Garcia de la Mària C, Hernandez-Meneses M, Vidal B, Sandoval E, Quintana E, Fuster D, Tolosana JM, Marco F, Moreno A, Miro JM; Hospital Clínic Infective Endocarditis Investigators.

Clin Infect Dis. 2018 Jan 6;66(1):104-111. doi: 10.1093/cid/cix752.

PMID:
29020360
25.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.

26.

Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study.

Ambrosioni J, Artigues F, Nicolás D, Peñafiel J, Agüero F, Manzardo C, Mar Mosquera M, Sánchez-Palomino S, De Lazzari E, Marcos MA, Plana M, Miró JM; Hospital Clinic PHI Investigators.

J Neurovirol. 2017 Oct;23(5):679-685. doi: 10.1007/s13365-017-0548-6. Epub 2017 Jul 17.

PMID:
28718069
27.

The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana JM, Vidal B, Almela M, Quintana E, Llopis J, Moreno A, Miro JM; Hospital Clinic Infective Endocarditis Investigators.

Curr Infect Dis Rep. 2017 May;19(5):21. doi: 10.1007/s11908-017-0574-9. Review.

PMID:
28401448
28.

Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.

Coiras M, Ambrosioni J, Cervantes F, Miró JM, Alcamí J.

Expert Opin Drug Saf. 2017 May;16(5):547-559. doi: 10.1080/14740338.2017.1313224. Epub 2017 Apr 26. Review.

PMID:
28387147
29.

AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

Castañeda X, García-de-la-Mària C, Gasch O, Pericas JM, Armero Y, Soy D, García-González J, Falces C, Ninot S, Almela M, Ambrosioni J, Quintana E, Vidal B, Fuster D, Llopis J, Soto S, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02486-16. doi: 10.1128/AAC.02486-16. Print 2017 Jun.

30.

Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response.

Ambrosioni J, Mosquera MM, Miró JM.

J Antimicrob Chemother. 2017 May 1;72(5):1547-1548. doi: 10.1093/jac/dkx071. No abstract available.

PMID:
28333247
31.

Potential role of tyrosine kinase inhibitors during primary HIV-1 infection.

Ambrosioni J, Coiras M, Alcamí J, Miró JM.

Expert Rev Anti Infect Ther. 2017 May;15(5):421-423. doi: 10.1080/14787210.2017.1308823. Epub 2017 Mar 30. No abstract available.

PMID:
28322065
32.

Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.

Cillóniz C, Torres A, Manzardo C, Gabarrús A, Ambrosioni J, Salazar A, García F, Ceccato A, Mensa J, de la Bella Casa JP, Moreno A, Miró JM.

Chest. 2017 Aug;152(2):295-303. doi: 10.1016/j.chest.2017.03.007. Epub 2017 Mar 14.

PMID:
28302496
33.

Comparative analysis of viral shedding in pediatric and adult subjects with central nervous system-associated enterovirus infections from 2013 to 2015 in Switzerland.

Cordey S, Schibler M, L'Huillier AG, Wagner N, Gonçalves AR, Ambrosioni J, Asner S, Turin L, Posfay-Barbe KM, Kaiser L.

J Clin Virol. 2017 Apr;89:22-29. doi: 10.1016/j.jcv.2017.01.008. Epub 2017 Feb 7.

34.

Comment on: Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

Ambrosioni J, Mosquera MM, Miró JM.

J Antimicrob Chemother. 2017 May 1;72(5):1548-1549. doi: 10.1093/jac/dkx015. No abstract available.

PMID:
28160503
35.

Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.

Nicolás D, Ambrosioni J, Sued O, Brunet M, López-Diéguez M, Manzardo C, Agüero F, Tuset M, Plana M, Guardo AC, Mosquera MM, Muñoz-Fernández MÁ, Caballero M, Marcos MÁ, Gatell JM, de Lazzari E, Gallart T, Miró JM.

J Antimicrob Chemother. 2017 Mar 1;72(3):829-836. doi: 10.1093/jac/dkw462.

PMID:
27999018
36.

Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.

Ambrosioni J, Nicolás D, Manzardo C, Agüero F, Blanco JL, Mosquera MM, Peñafiel J, Gatell JM, Marcos MA, Miró JM.

J Antimicrob Chemother. 2017 Jan;72(1):205-209. Epub 2016 Sep 13.

PMID:
27624569
37.

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.

Londoño MC, Manzardo C, Rimola A, Ruiz P, Costa J, Forner A, Ambrosioni J, Agüero F, Laguno M, Lligoña A, Moreno A, Miró JM.

J Antimicrob Chemother. 2016 Nov;71(11):3195-3201. Epub 2016 Jul 7.

PMID:
27402009
38.

Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4].

Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J.

New Microbes New Infect. 2015 Jul 31;8:174. doi: 10.1016/j.nmni.2015.07.004. eCollection 2015 Nov.

39.

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.

Nicolás D, Esteve A, Cuadros A, Campbell CNJ, Tural C, Podzamczer D, Murillas J, Homar F, Segura F, Force L, Vilaró J, Masabeu À, Garcia I, Mercadal J, Montoliu A, Ferrer E, Riera M, Cifuentes C, Ambrosioni J, Navarro G, Manzardo C, Clotet B, Gatell JM, Casabona J, Miró JM; PISCIS Cohort Study Investigators, Murillas J, Manzardo C, Masabeu A, Mercadal J, Cifuentes C, Dalmau D, Domingo P, Falcó V, Curran A, Agustí C, Montoliu A, Pérez I, Curto J, Gargoulas F, Gómez A, Rubia JC, Zamora L, Blanco JL, Garcia-Alcaide F, Martínez E, Mallolas J, Llibre JM, Sirera G, Romeu J, Jou A, Negredo E, Saumoy M, Imaz A, Bolao F, Cabellos C, Peña C, DiYacovo S, Van Den Eynde E, Sala M, Cervantes M, Amengual MJ, Navarro M, Segura V, Barrufet P, Molina J, Alvaro M, Payeras T, Gracia Mateo M, Fernández J.

Clin Infect Dis. 2016 Jun 15;62(12):1578-1585. doi: 10.1093/cid/ciw157. Epub 2016 Apr 28.

PMID:
27126346
40.

Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection.

Sanchez-Merino V, Fabra-Garcia A, Gonzalez N, Nicolas D, Merino-Mansilla A, Manzardo C, Ambrosioni J, Schultz A, Meyerhans A, Mascola JR, Gatell JM, Alcami J, Miro JM, Yuste E.

J Virol. 2016 May 12;90(11):5231-5245. doi: 10.1128/JVI.00049-16. Print 2016 Jun 1.

41.

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.

Bermejo M, López-Huertas MR, García-Pérez J, Climent N, Descours B, Ambrosioni J, Mateos E, Rodríguez-Mora S, Rus-Bercial L, Benkirane M, Miró JM, Plana M, Alcamí J, Coiras M.

Biochem Pharmacol. 2016 Apr 15;106:30-45. doi: 10.1016/j.bcp.2016.02.002. Epub 2016 Feb 4.

PMID:
26851491
42.

Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patient.

Ambrosioni J, Coll S, Manzardo C, Nicolás D, Agüero F, Blanco JL, Tuset M, Brunet M, Gatell JM, Miró JM.

J Antimicrob Chemother. 2016 Apr;71(4):1125-7. doi: 10.1093/jac/dkv449. Epub 2016 Jan 10. No abstract available.

PMID:
26755498
43.

The continuum of HIV care in Catalonia.

Campbell CN, Ambrosioni J, Miro JM, Esteve A, Casabona J, Navarro G, García I, Ferrer E, Force L, Tural C.

AIDS Care. 2015;27(12):1449-54. doi: 10.1080/09540121.2015.1109584. Epub 2015 Nov 25.

PMID:
26605781
44.

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.

Kovari H, Russmann S, Ledergerber B, Müller D, Rotger M, Velli P, Cavassini M, Ambrosioni J, Bregenzer A, Stöckle M, Bernasconi E, Rauch A, Speck RF; Swiss HIV Cohort Study.

PLoS One. 2015 Jul 28;10(7):e0133879. doi: 10.1371/journal.pone.0133879. eCollection 2015.

45.

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes.

Sued O, Ambrosioni J, Nicolás D, Manzardo C, Agüero F, Claramonte X, Plana M, Tuset M, Pumarola T, Gallart T, Gatell JM, Miró JM.

PLoS One. 2015 Jul 17;10(7):e0131651. doi: 10.1371/journal.pone.0131651. eCollection 2015.

46.

Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.

Schaerer V, Haubitz S, Kovari H, Ledergerber B, Ambrosioni J, Cavassini M, Stoeckle M, Schmid P, Decosterd L, Aouri M, Böni J, Günthard HF, Furrer H, Metzner KJ, Fehr J, Rauch A; Swiss HIV Cohort Study.

HIV Med. 2015 Nov;16(10):599-607. doi: 10.1111/hiv.12269. Epub 2015 Jul 2.

47.

Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.

Nicolás D, Ambrosioni J, Paredes R, Marcos MÁ, Manzardo C, Moreno A, Miró JM.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):947-63. doi: 10.1586/14787210.2015.1056157. Epub 2015 Jun 25. Review.

PMID:
26112187
48.

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.

Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J.

New Microbes New Infect. 2015 Feb 27;6:1-4. doi: 10.1016/j.nmni.2015.02.003. eCollection 2015 Jul. Review. Erratum in: New Microbes New Infect. 2015 Nov;8:174.

49.

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).

Ambrosioni J, Sued O, Nicolas D, Parera M, López-Diéguez M, Romero A, Agüero F, Marcos MÁ, Manzardo C, Zamora L, Gómez-Carrillo M, Gatell JM, Pumarola T, Miró JM.

PLoS One. 2015 Jun 3;10(6):e0125837. doi: 10.1371/journal.pone.0125837. eCollection 2015.

50.

Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013.

Wandeler G, Schlauri M, Jaquier ME, Rohrbach J, Metzner KJ, Fehr J, Ambrosioni J, Cavassini M, Stöckle M, Schmid P, Bernasconi E, Keiser O, Salazar-Vizcaya L, Furrer H, Rauch A; Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schöni-Affolter F, Schmid P, Schüpbach J, Speck R, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S.

Open Forum Infect Dis. 2015 Mar 25;2(1):ofv026. doi: 10.1093/ofid/ofv026. eCollection 2015 Jan.

Supplemental Content

Loading ...
Support Center